NuCana (NCNA) Interest & Investment Income (2017 - 2025)
NuCana (NCNA) reported Interest & Investment Income of $230118.8 for Q4 2025, up 139.05% on a YoY basis from $96262.6 in Q4 2024, and up 11.46% sequentially from $206452.4 in Q3 2025.
NuCana (NCNA) Interest & Investment Income (2017 - 2025) Analysis & Trends
NuCana (NCNA) has 9 years of Interest & Investment Income data on file, last reported at $230118.8 in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income rose 139.05% year-over-year to $230118.8; the trailing twelve-month figure through Dec 2025 stood at $514750.3 (up 12.65% YoY), and the FY2025 full-year result was $508945.0, up 11.22% from the prior year.
- Interest & Investment Income advanced to $230118.8 in Q4 2025, from $206452.4 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $348851.2 in Q1 2023 to a low of $29656.2 in Q4 2021.
- A 5-year average of $142461.1 and a median of $133561.0 in 2024 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income tumbled 82.07% in 2021 and jumped 1043.02% in 2022, its largest moves.
- Tracing NCNA's Interest & Investment Income over 5 years: stood at $29656.2 in 2021, then jumped by 1043.02% to $338976.3 in 2022, then plunged by 49.84% to $170037.8 in 2023, then tumbled by 43.39% to $96262.6 in 2024, then surged by 139.05% to $230118.8 in 2025.
- Business Quant data shows NCNA's Interest & Investment Income at $230118.8 in Q4 2025, $206452.4 in Q3 2025, and $46691.6 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | NuCana | 14.38 Bn | 14.34 Bn | - | 230,118.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 230,118.75 |
| Sep 30, 2025 | 206,452.41 |
| Jun 30, 2025 | 46,691.60 |
| Mar 31, 2025 | 31,487.51 |
| Dec 31, 2024 | 96,262.64 |
| Sep 30, 2024 | 93,549.61 |
| Jun 30, 2024 | 107,288.76 |
| Mar 31, 2024 | 159,833.29 |
| Dec 31, 2023 | 170,037.81 |
| Sep 30, 2023 | 192,536.09 |
| Jun 30, 2023 | 222,742.64 |
| Mar 31, 2023 | 348,851.23 |
| Dec 31, 2022 | 338,976.28 |
| Sep 30, 2022 | 254,566.43 |
| Jun 30, 2022 | 166,229.47 |
| Mar 31, 2022 | 41,596.91 |
| Dec 31, 2021 | 29,656.23 |
| Sep 30, 2021 | 30,328.83 |
| Jun 30, 2021 | 48,920.49 |
| Mar 31, 2021 | 33,094.10 |